Traditional Chinese Medicine for Lung Cancer — Reducing Recurrence and Supporting Recovery
For lung cancer patients seeking to complement their Western oncology treatment with evidence-based Traditional Chinese Medicine, Shanghai's Longhua Hospital offers one of China's most respected integrative oncology programs. Prof. Liu Lingshuang carries forward a lineage of TCM cancer treatment that spans generations — and her clinical research has demonstrated that integrated TCM protocols can reduce postoperative recurrence and metastasis risk by 27%.
Featured Specialist: Prof. Liu Lingshuang (刘苓霜)
Prof. Liu Lingshuang is a leading TCM oncologist at Longhua Hospital, Shanghai University of Traditional Chinese Medicine (Shanghai Zhongyiyao Daxue Fushu Longhua Yiyuan) — one of China's most prestigious TCM hospitals and a nationally designated key center for TCM oncology research and clinical practice.
Prof. Liu is the designated successor of National Master of Traditional Chinese Medicine Liu Jiaxiang (刘嘉湘) — one of China's most revered TCM oncologists, whose "Fu Zheng Zhi Ai" (扶正治癌, "Strengthen the Righteous to Treat Cancer") philosophy has shaped TCM cancer treatment for decades. This lineage represents the highest level of TCM oncology expertise in China.
Prof. Liu's clinical research has produced a landmark finding:
- Her integrated TCM comprehensive treatment protocol reduces postoperative recurrence and metastasis risk by 27% in lung cancer patients — a clinically meaningful reduction that complements the benefits of surgery, chemotherapy, and targeted therapy
The "Fu Zheng Zhi Ai" Philosophy
The foundational principle of Prof. Liu's approach — inherited from National Master Liu Jiaxiang — is "Fu Zheng Zhi Ai" (扶正治癌): strengthening the body's righteous Qi (vital energy and immune capacity) as the primary strategy for treating cancer. This philosophy holds that:
- Cancer arises in part from a deficiency of the body's defensive and regulatory capacity
- Restoring and strengthening this capacity — through herbal medicine, acupuncture, and lifestyle guidance — creates an internal environment less hospitable to cancer growth and recurrence
- TCM treatment should not merely attack the tumor (which risks further depleting the patient's vital resources) but should simultaneously support the patient's constitution
- This approach is particularly valuable during and after Western oncology treatment, when the body's resources are depleted by surgery, chemotherapy, and radiation
How TCM Integrates with Lung Cancer Treatment
Prof. Liu's integrative protocols are designed to work alongside — not instead of — Western oncology treatment at every stage of the lung cancer journey:
Perioperative Period (Before and After Surgery)
- Pre-operative herbal medicine to strengthen constitution and optimize surgical tolerance
- Post-operative recovery support: accelerating wound healing, restoring lung function, reducing fatigue
- Immune reconstitution after surgical stress
- 27% reduction in postoperative recurrence and metastasis risk with comprehensive TCM protocol
During Chemotherapy
- Reducing nausea, vomiting, and appetite loss
- Protecting bone marrow function and reducing chemotherapy-induced myelosuppression
- Managing peripheral neuropathy from taxane or platinum chemotherapy
- Maintaining energy and performance status to allow completion of full chemotherapy courses
- Liver protection during hepatotoxic chemotherapy regimens
During Targeted Therapy
- Managing skin rash and diarrhea from EGFR inhibitors
- Reducing fatigue and maintaining quality of life during long-term targeted therapy
- Supporting liver function during prolonged TKI use
- Potential role in delaying or managing targeted therapy resistance (active research area)
During Radiation Therapy
- Reducing radiation pneumonitis risk and severity
- Managing radiation-induced esophagitis for centrally located tumors
- Fatigue management and immune support during radiotherapy
Long-Term Survivorship
- Constitutional strengthening to reduce recurrence risk
- Management of long-term treatment sequelae
- Ongoing immune surveillance support
- Quality of life optimization for patients in remission
About Longhua Hospital
Longhua Hospital is affiliated with Shanghai University of Traditional Chinese Medicine and is one of China's most respected TCM hospitals, with a history spanning over 60 years. Its oncology department is a nationally designated key clinical specialty, and its TCM cancer research program is among the most productive in China. The hospital operates within Shanghai's broader medical ecosystem, enabling coordination with Western oncology centers across the city.
How CMCS Coordinates Your Integrative Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading integrative oncology specialists, including Prof. Liu Lingshuang at Longhua Hospital, and manage every step of the process:
- Review of existing Western treatment records and current medications for herb-drug interaction screening
- Consultation scheduling with Prof. Liu's TCM oncology team
- Coordination with Western oncology teams (thoracic surgery, medical oncology, radiation oncology) for integrated planning
- Medical interpretation during TCM consultations
- Guidance on herbal medicine preparation and administration for international patients
- Remote follow-up coordination for patients returning to their home countries
Get in Touch
If you are interested in integrating Traditional Chinese Medicine into your lung cancer treatment plan in Shanghai, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 comentarios